Pharma join together to achieve new standards in digital and patient innovation for clinical transformation Read more
Cerveau Technologies Inc. Signs Agreement with Roche to Provide Novel Tau Imaging Biomarker for Disease Modifier Research Read more
Moderna Announces First Participant Dosed in Phase 2 Study of Omicron-Specific Bivalent Booster Candidate Read more
Erasca Announces Clinical Trial Collaboration and Supply Agreement with Eli Lilly and Company to Evaluate ERAS-007 and Cetuximab Combination Read more
Aeterna Zentaris Announces Expansion of Research Program with Julius-Maximilians-University Wuerzburg Aiming to Accelerate Development of Vaccine Programs Read more
Intellia Therapeutics Receives FDA Orphan Drug Designation for NTLA-5001 for the Treatment of Acute Myeloid Leukemia Read more
Twist Bioscience and Kriya Sign Agreement to Discover Novel Antibodies for Applications in Oncology Using Gene Therapy Read more
Insilico Medicine enters research collaboration with the University of Zurich to apply Insilico’s generative Artificial Intelligence platform for the discovery of potential therapeutics for Cystinosis Read more
Pfizer Initiates Phase 2/3 Study of Novel COVID-19 Oral Treatment in Pediatric Participants Read more